Data Protection in China: 17 Years after China's WTO Accession

Wenting Cheng

    Research output: Contribution to journalArticlepeer-review


    China introduced dual data protection (both undisclosed information and six-year data exclusivity) for pharmaceutical products from its accession to the WTO. From 2017, a new series of policies proposed up to 12 years of data exclusivity for biologics. The drug negotiation mechanism in China should be considered in evaluating the impacts of these policies on enhanced data protection
    Original languageEnglish
    Pages (from-to)292-297
    JournalEuropean Intellectual Property Review (E.I.P.R)
    Issue number5
    Publication statusPublished - 2018


    Dive into the research topics of 'Data Protection in China: 17 Years after China's WTO Accession'. Together they form a unique fingerprint.

    Cite this